The Supreme Court Is Going To Decide If Biotech Companies Can 'Patent Nature'

The U.S. Supreme Court decided in a closed-door meeting Friday it's going to hear an epic fight over whether companies can patent isolated genes. The high court is limiting its review to whether companies can patent the process of taking the human gene out of the body for research, SCOTUSBlog reported. The case centers on two Myriad Genetics patents for genes that show whether women have increased chances of getting breast or ovarian cancer. Cancer groups and patients challenged the patents on t...